JADPRO Live 2024 | Cancer Nursing Today
Find important meeting news and updates from JADPRO Live 2024, the Annual APSHO Meeting, held November 14-17, in Grapevine, Texas.
Related Articles
Kidney Ball | National Kidney Foundation of Michigan
The “most fun black tie event in Metro Detroit” began 16 years ago as a one-time event to commemorate the 50th Anniversary of the NKFM.
JADPRO Live 2024 | Cancer Nursing Today
Find important meeting news and updates from JADPRO Live 2024, the Annual APSHO Meeting, held November 14-17, in Grapevine, Texas.
JADPRO Live 2024 | Cancer Nursing Today
Find important meeting news and updates from JADPRO Live 2024, the Annual APSHO Meeting, held November 14-17, in Grapevine, Texas.
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
This ESMO Clinical Practice Guideline (CPG) focuses on invasive cutaneous melanoma. The management of uveal melanoma and non-melanoma skin cancers are described in separate ESMO…
TCTMD – tctmd.com
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
Vitamin D supplementation may decrease blood pressure in obese older adults
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does…
Incidental Coronary Artery Calcification and the Risk of Major Adverse Cardiovascular Outcomes
Background Incidental findings of coronary artery calcifications (CACs) are not consistently reported, and the clinical significance relating to cardiovascular outcomes remains to be establis…
Paper: Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Addressing Hematologic and Immune Toxicities and the Status of Quad Therapies…
Paper: Previous HDM/ASCT Adversely Impacts PFS with BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
Program: Oral and Poster Abstracts Ty pe: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Decluttering Responses and Dynamic Risk: How Can We Improve Prognostication…
Paper: Tocilizumab Prophylaxis for Patients with Relapsed or Refractory Multiple Myeloma Treated with Teclistamab, Elranatamab or Talquetamab
Program: O ral and Poster Abstracts Type: Oral Session: 907. Outcomes Research: Plasma Cell Disorders: Bispecific Antibodies and CAR-T Therapies in Myeloma-The Yin and Yang…